Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Oct 16, 2021; 9(29): 8718-8728
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8718
Table 1 Clinicopathological features of patients undergoing gastrectomy plus pancreatectomy and palliative gastrectomy alone
Variable
GP group, (n = 24) (%)
GA group, (n = 52) (%)
P value
Gender0.486
Male22 (91.7)43 (82.7)
Female2 (8.3)9 (17.3)
Age (yr)0.254
< 6516 (66.7)41 (78.8)
≥ 658 (33.3)11 (21.2)
BMI (kg/m2)23.5 ± 3.523.2 ± 3.30.779
ASA score 0.45
< 316 (66.7)39 (75.0)
≥ 38 (33.3)13 (25.0)
Neoadjuvant chemotherapy< 0.001
Yes10 (41.7)44 (84.6)
No14 (58.3)8 (15.4)
Postoperative therapy0.199
Chemotherapy11 (45.8)32 (61.5)
Chemoradiotherapy 13 (54.2)20 (38.5)
Preoperative albumin (g/L)37.9 ± 4.936.3 ± 5.10.083
Preoperative hemoglobin (g/L)119.0 ± 28.2108.3 ± 26.50.058
Linitis plastica0.059
Yes1 (4.2)11 (21.2)
No23 (95.8)41 (78.8)
Borrmann type0.312
I1 (4.2)1 (1.9)
II8 (33.3)18 (34.6)
III14 (58.3)23 (44.2)
IV1 (4.2)10 (19.2)
Tumor size (cm)9.3 ± 2.36.7 ± 1.9< 0.001
Histological type 0.945
Poorly differentiated20 (83.3)43 (82.7)
Well–moderately differentiated4 (16.7)9 (17.3)
Pathological N stage0.03
N00 (0.0)0 (0.0)
N10 (0.0)0 (0.0)
N25 (20.8)17 (32.7)
N3a5 (20.8)16 (30.8)
N3b14 (58.3) 19 (36.5)
Lymphovascular invasion 0.168
Yes22 (91.7)41 (78.8)
No2 (8.3)11 (21.2)
Neural invasion0.638
Yes17 (70.8)34 (65.4)
No7 (29.2)18 (34.6)
Surgical margin< 0.001
R021 (87.5)0 (0.0)
R13 (12.5)52 (88.5)
Table 2 Surgical outcome of patients undergoing gastrectomy plus pancreatectomy and gastrectomy alone
Variable
GP group, (n = 24) (%)
GA group, (n = 52) (%)
P value
Intraoperative blood loss (mL)443.8 ± 104.6144.2 ± 64.7< 0.001
Operation time (min)223.3 ± 41.6192.9 ± 29.60.003
Postoperative hospital stay (d)18.2 ± 5.910 ± 3.6 < 0.001
Postoperative mortality1 (4.2)2 (3.8)1
Postoperative morbidity8 (33.3)8 (15.3)0.128
Local complications5 (20.8)6 (11.5)0.324
Abdominal infection10
Anastomotic fistula01
Abdominal hemorrhage10
Gastrointestinal hemorrhage01
Disruption of wound10
Pancreatic fistula23
Duodenal stump fistula01
Systemic complications3 (12.5)2 (3.8)0.177
Pulmonary infection10
Pneumothorax11
Renal failure00
Diabetic ketoacidosis10
Cardio- and cerebrovascular event01
Clavien–Dindo classification0.309
II13
IIIa21
IIIb31
IVa10
IVb01
V12
Table 3 Univariate and multivariate analysis of prognostic factors for pT4 gastric cancer with pancreatic head invasion
VariableUnivariate analysis
Multivariate analysis
HR (95%CI)
P value
HR (95%CI)
P value
Age ≥ 65/< 65 yr1.19 (0.567–2.505)0.644
Gender (male/female)1.01 (0.369–2.101)0.346
Preoperative hemoglobin < 35 g/L (yes/no)1.09 (0.423–3.205)0.524
Preoperative anemia1.18 (0.523–2.985)0.502
(hemoglobin < 90 g/L) (yes/no)
Neoadjuvant chemotherapy (yes/no)0.180 (0.073–0.446)< 0.0010.29 (00.103–0.821) 0.02
Operation type (GP/GA)0.393 (0.188–0.819)0.0130.689 (0.157–3.019)0.621
Borrmann type0.159
I1
II1.399 (0.266–7.358)0.692
III0.479 (0.164–1.403)0.179
IV0.398 (0.144–1.100)0.076
Tumor diameter > 7/≤ 7 cm0.380 (0.190–0.758)0.006
Tumor type (linitis plastica/not)2.764 (1.127–6778)0.0262.614 (1.024–6.675)0.033
Intraoperative blood loss > 400mL (yes/no)1.089 (0.347–2.102)0.154
Operation time > 240 min 1.021 (0.233–3.112)0.423
Surgical margin (R0/R1)2.501 (1.177–5.314)0.0170.274 (0.102–0.738)0.01
Lymphovascular invasion (yes/no)2.512 (1.066–5.921)0.0351.517 (0.930–2.476)0.095
Perineural invasion (yes/no)1.545 (0.781–3.054)0.211
Differentiation type (poor/well–moderate)1.358 (0.610–3.021)0.454
N stage(N0/N1/N2/N3a/N3b)1.708 (1.103–2.644)0.0163.489 (1.334–9.120)0.011
Postoperative treatment (chemotherapy/chemoradiotherapy) 0.347 (0.159–0.757)0.0080.369 (0.163–0.836)0.017